Friday, 23 December 2011

Minims Atropine




Minims Atropine may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

UK matches:

  • Minims Atropine Sulphate
  • Minims Atropine Sulphate (SPC)

Ingredient matches for Minims Atropine



Atropine

Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Minims Atropine in the following countries:


  • Australia

  • Ireland

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Ketoprom




Ketoprom may be available in the countries listed below.


Ingredient matches for Ketoprom



Ketoprofen

Ketoprofen is reported as an ingredient of Ketoprom in the following countries:


  • Poland

International Drug Name Search

Simvastamed




Simvastamed may be available in the countries listed below.


Ingredient matches for Simvastamed



Simvastatin

Simvastatin is reported as an ingredient of Simvastamed in the following countries:


  • Belgium

International Drug Name Search

Saturday, 17 December 2011

Halfan




In the US, Halfan (halofantrine systemic) is a member of the drug class miscellaneous antimalarials and is used to treat Malaria.

US matches:

  • Halfan

Ingredient matches for Halfan



Halofantrine

Halofantrine hydrochloride (a derivative of Halofantrine) is reported as an ingredient of Halfan in the following countries:


  • Bahrain

  • France

  • Iran

  • Kuwait

  • Luxembourg

  • Portugal

  • Qatar

  • South Africa

  • United Arab Emirates

International Drug Name Search

Friday, 16 December 2011

Antup R




Antup R may be available in the countries listed below.


Ingredient matches for Antup R



Isosorbide Dinitrate

Isosorbide Dinitrate is reported as an ingredient of Antup R in the following countries:


  • Japan

International Drug Name Search

Friday, 9 December 2011

Alfuzosine Qualimed L.P.




Alfuzosine Qualimed L.P. may be available in the countries listed below.


Ingredient matches for Alfuzosine Qualimed L.P.



Alfuzosin

Alfuzosin hydrochloride (a derivative of Alfuzosin) is reported as an ingredient of Alfuzosine Qualimed L.P. in the following countries:


  • France

International Drug Name Search

Tuesday, 6 December 2011

Fluoxetin 1A Farma




Fluoxetin 1A Farma may be available in the countries listed below.


Ingredient matches for Fluoxetin 1A Farma



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetin 1A Farma in the following countries:


  • Denmark

International Drug Name Search

Sunday, 4 December 2011

Nitrazepam Katwijk




Nitrazepam Katwijk may be available in the countries listed below.


Ingredient matches for Nitrazepam Katwijk



Nitrazepam

Nitrazepam is reported as an ingredient of Nitrazepam Katwijk in the following countries:


  • Netherlands

International Drug Name Search

Tuesday, 15 November 2011

Fosace




Fosace may be available in the countries listed below.


Ingredient matches for Fosace



Fosinopril

Fosinopril is reported as an ingredient of Fosace in the following countries:


  • Slovenia

International Drug Name Search

Monday, 14 November 2011

Aulcer




Aulcer may be available in the countries listed below.


Ingredient matches for Aulcer



Omeprazole

Omeprazole is reported as an ingredient of Aulcer in the following countries:


  • Peru

  • Spain

International Drug Name Search

Friday, 11 November 2011

Airomir




Airomir may be available in the countries listed below.


Ingredient matches for Airomir



Salbutamol

Salbutamol is reported as an ingredient of Airomir in the following countries:


  • Luxembourg

  • Norway

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Airomir in the following countries:


  • Argentina

  • Australia

  • Belgium

  • Canada

  • Chile

  • Costa Rica

  • Denmark

  • El Salvador

  • Finland

  • Guatemala

  • Honduras

  • Ireland

  • Japan

  • Luxembourg

  • Malaysia

  • Netherlands

  • Panama

  • Philippines

  • Sweden

  • United Kingdom

International Drug Name Search

Monday, 7 November 2011

Atenololo EG




Atenololo EG may be available in the countries listed below.


Ingredient matches for Atenololo EG



Atenolol

Atenolol is reported as an ingredient of Atenololo EG in the following countries:


  • Italy

International Drug Name Search

Quetiapine Zeneca




Quetiapine Zeneca may be available in the countries listed below.


Ingredient matches for Quetiapine Zeneca



Quetiapine

Quetiapine fumarate (a derivative of Quetiapine) is reported as an ingredient of Quetiapine Zeneca in the following countries:


  • Luxembourg

International Drug Name Search

Friday, 4 November 2011

Evra




Evra may be available in the countries listed below.


UK matches:

  • Evra transdermal patch (SPC)

Ingredient matches for Evra



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Evra in the following countries:


  • Austria

  • Bahrain

  • Belgium

  • Canada

  • Colombia

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Finland

  • France

  • Germany

  • Greece

  • Hong Kong

  • Hungary

  • Italy

  • Luxembourg

  • Netherlands

  • Norway

  • Oman

  • Peru

  • Poland

  • Portugal

  • Slovakia

  • South Africa

  • Spain

  • Sweden

  • Switzerland

  • Taiwan

  • Thailand

  • United Kingdom

  • Venezuela

  • Vietnam

Norelgestromin

Norelgestromin is reported as an ingredient of Evra in the following countries:


  • Austria

  • Bahrain

  • Belgium

  • Canada

  • Colombia

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Finland

  • France

  • Germany

  • Greece

  • Hong Kong

  • Hungary

  • Italy

  • Luxembourg

  • Netherlands

  • Norway

  • Oman

  • Peru

  • Poland

  • Portugal

  • Slovakia

  • South Africa

  • Spain

  • Sweden

  • Switzerland

  • Taiwan

  • Thailand

  • United Kingdom

  • Venezuela

  • Vietnam

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 3 November 2011

Ecostatin




Ecostatin may be available in the countries listed below.


Ingredient matches for Ecostatin



Econazole

Econazole nitrate (a derivative of Econazole) is reported as an ingredient of Ecostatin in the following countries:


  • Ireland

  • United Kingdom

International Drug Name Search

Friday, 28 October 2011

Lidocaina Comiesa




Lidocaina Comiesa may be available in the countries listed below.


Ingredient matches for Lidocaina Comiesa



Lidocaine

Lidocaine is reported as an ingredient of Lidocaina Comiesa in the following countries:


  • Peru

International Drug Name Search

Monday, 24 October 2011

Diclomax Retard




Diclomax Retard may be available in the countries listed below.


Ingredient matches for Diclomax Retard



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclomax Retard in the following countries:


  • Ireland

International Drug Name Search

Monday, 17 October 2011

Celestone


Celestone is a brand name of betamethasone, approved by the FDA in the following formulation(s):


CELESTONE (betamethasone - syrup; oral)



  • Manufacturer: SCHERING

    Approved Prior to Jan 1, 1982

    Strength(s): 0.6MG/5ML [RLD]

Has a generic version of Celestone been approved?


No. There is currently no therapeutically equivalent version of Celestone available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Celestone. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Celestone.

See also...

  • Celestone Solution Consumer Information (Wolters Kluwer)
  • Celestone Consumer Information (Cerner Multum)
  • Betamethasone Consumer Information (Wolters Kluwer)
  • Betamethasone Solution Consumer Information (Wolters Kluwer)
  • Betamethasone Consumer Information (Cerner Multum)
  • Betamethasone AHFS DI Monographs (ASHP)
  • Betamethasone Acetate AHFS DI Monographs (ASHP)

Friday, 14 October 2011

Dialume


Generic Name: aluminum hydroxide (a LOO mi num hye DROX ide)

Brand Names: Alternagel


What is Dialume (aluminum hydroxide)?

Aluminum is a naturally occurring mineral. Aluminum hydroxide is an antacid.


Aluminum hydroxide is used to treat symptoms of increased stomach acid, such as heartburn, upset stomach, sour stomach, or acid indigestion. Aluminum hydroxide is also used to reduce phosphate levels in people with certain kidney conditions.


Aluminum hydroxide may be used for other purposes not listed in this medication guide.


What is the most important information I should know about Dialume (aluminum hydroxide)?


Ask a doctor or pharmacist before taking this medication if you have kidney disease, kidney stones, severe constipation, if you are dehydrated, or if you drink alcohol frequently.


Do not take aluminum hydroxide for longer than 2 weeks without your doctor's advice.

Avoid taking other medications at the same time you take aluminum hydroxide. Antacids can make it harder for your body to absorb certain other drugs.


What should I discuss with my healthcare provider before taking Dialume (aluminum hydroxide)?


Ask a doctor or pharmacist if it is safe for you to take this medication if you have:


  • kidney disease, a history of kidney stones;


  • severe constipation;




  • if you are dehydrated; or




  • if you drink alcohol frequently.




It is not known whether aluminum hydroxide is harmful to an unborn baby. Before taking this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment. Aluminum hydroxide may pass into breast milk and could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I take Dialume (aluminum hydroxide)?


Use this medication exactly as directed on the label, or as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended.


Shake the oral suspension (liquid) well just before you measure a dose. To be sure you get the correct dose, measure the liquid with a marked measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one. Take this medication with a full glass (8 ounces) of water.

Aluminum hydroxide is usually taken between meals or at bedtime.


Do not take aluminum hydroxide for longer than 2 weeks without your doctor's advice. Store aluminum hydroxide at room temperature away from moisture, heat, and light.

What happens if I miss a dose?


Since antacids are usually taken as needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include severe constipation, weight loss, confusion, mood changes, or urinating less than usual or not at all.


What should I avoid while taking Dialume (aluminum hydroxide)?


Avoid taking other medications at the same time you take aluminum hydroxide. Antacids can make it harder for your body to absorb certain other drugs.


Dialume (aluminum hydroxide) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using the medication and call your doctor at once if you have a serious side effect such as:

  • severe stomach pain or constipation;




  • bloody, black, or tarry stools;




  • coughing up blood that looks like coffee grounds;




  • pain when you urinate;




  • extreme drowsiness; or




  • tired feeling, loss of appetite, and muscle weakness.



Less serious side effects are more likely, and you may have none at all.


This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Dialume (aluminum hydroxide)?


There may be other drugs that can interact with aluminum hydroxide. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More Dialume resources


  • Dialume Side Effects (in more detail)
  • Dialume Use in Pregnancy & Breastfeeding
  • Dialume Drug Interactions
  • Dialume Support Group
  • 0 Reviews for Dialume - Add your own review/rating


Compare Dialume with other medications


  • Duodenal Ulcer
  • Erosive Esophagitis
  • Gastrointestinal Hemorrhage
  • GERD
  • Hyperphosphatemia
  • Indigestion
  • Peptic Ulcer
  • Stomach Ulcer
  • Zollinger-Ellison Syndrome


Where can I get more information?


  • Your pharmacist can provide more information about aluminum hydroxide.

See also: Dialume side effects (in more detail)


Sunday, 9 October 2011

Sumatriptan Welding




Sumatriptan Welding may be available in the countries listed below.


Ingredient matches for Sumatriptan Welding



Sumatriptan

Sumatriptan succinate (a derivative of Sumatriptan) is reported as an ingredient of Sumatriptan Welding in the following countries:


  • Netherlands

International Drug Name Search

Saturday, 8 October 2011

B-Cort




B-Cort may be available in the countries listed below.


Ingredient matches for B-Cort



Budesonide

Budesonide is reported as an ingredient of B-Cort in the following countries:


  • Colombia

International Drug Name Search

Sunday, 2 October 2011

Cetiristad




Cetiristad may be available in the countries listed below.


Ingredient matches for Cetiristad



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cetiristad in the following countries:


  • Austria

  • Bulgaria

International Drug Name Search

Tuesday, 27 September 2011

Rum-K




In the US, Rum-K (potassium chloride systemic) is a member of the drug class minerals and electrolytes and is used to treat Hypokalemia and Prevention of Hypokalemia.

US matches:

  • Rum-K Liquid

  • Rum-K

Ingredient matches for Rum-K



Potassium Chloride

Potassium Chloride is reported as an ingredient of Rum-K in the following countries:


  • United States

International Drug Name Search

Monday, 26 September 2011

Glukozamin




Glukozamin may be available in the countries listed below.


Ingredient matches for Glukozamin



Glucosamine

Glucosamine sulfate (a derivative of Glucosamine) is reported as an ingredient of Glukozamin in the following countries:


  • Hungary

International Drug Name Search

Deltacortril




Deltacortril may be available in the countries listed below.


UK matches:

  • Deltacortril Gastro-resistant Tablets
  • Deltacortril Gastro-resistant Tablets (SPC)

Ingredient matches for Deltacortril



Prednisolone

Prednisolone is reported as an ingredient of Deltacortril in the following countries:


  • Greece

  • Ireland

  • Luxembourg

  • Turkey

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 20 September 2011

Doxazosin beta




Doxazosin beta may be available in the countries listed below.


Ingredient matches for Doxazosin beta



Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Doxazosin beta in the following countries:


  • Germany

International Drug Name Search

Monday, 19 September 2011

Calcium Syrup




Calcium Syrup may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Calcium Syrup



Calcium

Calcium mixture of several salts (a derivative of Calcium) is reported as an ingredient of Calcium Syrup in the following countries:


  • Australia

International Drug Name Search

Friday, 16 September 2011

Zycort




Zycort may be available in the countries listed below.


Ingredient matches for Zycort



Budesonide

Budesonide is reported as an ingredient of Zycort in the following countries:


  • Bangladesh

International Drug Name Search

Wednesday, 14 September 2011

Glucogood




Glucogood may be available in the countries listed below.


Ingredient matches for Glucogood



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Glucogood in the following countries:


  • Argentina

International Drug Name Search

Monday, 12 September 2011

Fenivir




Fenivir may be available in the countries listed below.


Ingredient matches for Fenivir



Penciclovir

Penciclovir is reported as an ingredient of Fenivir in the following countries:


  • Austria

  • Bulgaria

  • Greece

  • Hungary

  • Lithuania

  • South Africa

  • Switzerland

International Drug Name Search

Saturday, 27 August 2011

Diavix




Diavix may be available in the countries listed below.


Ingredient matches for Diavix



Lamivudine

Lamivudine is reported as an ingredient of Diavix in the following countries:


  • Bangladesh

Zidovudine

Zidovudine is reported as an ingredient of Diavix in the following countries:


  • Bangladesh

International Drug Name Search

Thursday, 25 August 2011

Febricol




Febricol may be available in the countries listed below.


Ingredient matches for Febricol



Ibuprofen

Ibuprofen is reported as an ingredient of Febricol in the following countries:


  • Chile

International Drug Name Search

Zink-ratiopharm




Zink-ratiopharm may be available in the countries listed below.


Ingredient matches for Zink-ratiopharm



Zinc Sulfate

Zinc Sulfate is reported as an ingredient of Zink-ratiopharm in the following countries:


  • Germany

International Drug Name Search

Friday, 19 August 2011

Clorhexol




Clorhexol may be available in the countries listed below.


Ingredient matches for Clorhexol



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Clorhexol in the following countries:


  • Colombia

International Drug Name Search

Sunday, 14 August 2011

Dolo-Dobendan




Dolo-Dobendan may be available in the countries listed below.


Ingredient matches for Dolo-Dobendan



Benzocaine

Benzocaine is reported as an ingredient of Dolo-Dobendan in the following countries:


  • Germany

Cetylpyridinium

Cetylpyridinium chloride (a derivative of Cetylpyridinium) is reported as an ingredient of Dolo-Dobendan in the following countries:


  • Germany

International Drug Name Search

Thursday, 11 August 2011

Magnesie Calcinee




Magnesie Calcinee may be available in the countries listed below.


Ingredient matches for Magnesie Calcinee



Magnesium Hydroxide

Magnesium Hydroxide is reported as an ingredient of Magnesie Calcinee in the following countries:


  • Turkey

International Drug Name Search

Monday, 8 August 2011

Actemra




In the US, Actemra (tocilizumab systemic) is a member of the drug class interleukin inhibitors and is used to treat Juvenile Idiopathic Arthritis and Rheumatoid Arthritis.

US matches:

  • Actemra

Ingredient matches for Actemra



Tocilizumab

Tocilizumab is reported as an ingredient of Actemra in the following countries:


  • Australia

  • Japan

  • Russian Federation

  • Switzerland

  • United States

International Drug Name Search

Wednesday, 3 August 2011

Zinasen




Zinasen may be available in the countries listed below.


Ingredient matches for Zinasen



Flunarizine

Flunarizine dihydrochloride (a derivative of Flunarizine) is reported as an ingredient of Zinasen in the following countries:


  • Peru

  • Portugal

International Drug Name Search

Tuesday, 2 August 2011

Acetilcisteina EG




Acetilcisteina EG may be available in the countries listed below.


Ingredient matches for Acetilcisteina EG



Acetylcysteine

Acetylcysteine is reported as an ingredient of Acetilcisteina EG in the following countries:


  • Italy

International Drug Name Search

Wednesday, 27 July 2011

Hagifen




Hagifen may be available in the countries listed below.


Ingredient matches for Hagifen



Ibuprofen

Ibuprofen is reported as an ingredient of Hagifen in the following countries:


  • Vietnam

International Drug Name Search

Friday, 22 July 2011

Leucovorin Kalbe




Leucovorin Kalbe may be available in the countries listed below.


Ingredient matches for Leucovorin Kalbe



Calcium Folinate

Calcium Folinate is reported as an ingredient of Leucovorin Kalbe in the following countries:


  • Indonesia

International Drug Name Search

Monday, 11 July 2011

Fluoxétine Alter




Fluoxétine Alter may be available in the countries listed below.


Ingredient matches for Fluoxétine Alter



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxétine Alter in the following countries:


  • France

International Drug Name Search

Wednesday, 6 July 2011

Orvaten


Generic Name: midodrine (Oral route)

MYE-doe-dreen

Oral route(Tablet)

Can cause marked elevation of supine blood pressure and should be used only in patients whose lives are considerably impaired despite standard clinical care .



Commonly used brand name(s)

In the U.S.


  • Orvaten

  • Proamatine

Available Dosage Forms:


  • Tablet

Therapeutic Class: Vasopressor


Pharmacologic Class: Alpha-Adrenergic Agonist


Uses For Orvaten


Midodrine is used to treat low blood pressure (hypotension). It works by stimulating nerve endings in blood vessels, causing the blood vessels to tighten. As a result, blood pressure is increased.


This medicine is available only with your doctor's prescription.


Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although not specifically included in product labeling, midodrine is used in certain patients with the following medical conditions:


  • Low blood pressure (hypotension) caused by kidney dialysis.

  • Low blood pressure caused by certain medicines used to treat mental illness.

  • Low blood pressure in children with an infection.

Before Using Orvaten


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


This medicine has been tested in a limited number of children 6 months to 12 years of age. In effective doses, the medicine has not been shown to cause different side effects or problems than it does in adults.


Geriatric


This medicine has been tested and has not been shown to cause different side effects or problems in older people than it dose in younger adults.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Dihydroergotamine

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Amitriptyline

  • Amoxapine

  • Clomipramine

  • Desipramine

  • Deslanoside

  • Digitoxin

  • Dothiepin

  • Doxepin

  • Ephedrine

  • Imipramine

  • Lofepramine

  • Nortriptyline

  • Opipramol

  • Phenylephrine

  • Phenylpropanolamine

  • Protriptyline

  • Pseudoephedrine

  • Trimipramine

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Perphenazine

  • Promethazine

  • Risperidone

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Heart disease, severe or

  • Hypertension (high blood pressure) or

  • Overactive thyroid or

  • Visual problems—Effects of midodrine on blood pressure may aggravate these problems.

  • Kidney disease or

  • Liver disease—The effects of midodrine may be increased because of slower removal of the medicine from the body.

  • Urinary retention—Effects of midodrine on the bladder may aggravate this condition.

Proper Use of midodrine

This section provides information on the proper use of a number of products that contain midodrine. It may not be specific to Orvaten. Please read with care.


The last dose of midodrine should not be taken after the evening meal or less than 3 to 4 hours before bedtime because high blood pressure upon lying down (supine hypertension) can occur, which can cause blurred vision, headaches, and pounding in the ears while lying down after taking this medicine.


Also, midodrine should not be taken if you will be lying down for any length of time.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (tablets):
    • For low blood pressure:
      • Adults—10 milligrams (mg) three times a day in approximately 4-hour intervals during daytime hours: shortly before or upon rising in the morning, at midday, and in the late afternoon (not later than 6 p.m.). Your doctor may increase your dose if needed.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using Orvaten


Do not take other medicines unless they have been discussed with your doctor. This especially includes over-the-counter (nonprescription) medicines for appetite control, asthma, colds, cough, hayfever, or sinus problems, since they may tend to increase your blood pressure.


Orvaten Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Blurred vision

  • cardiac awareness

  • headache

  • pounding in the ears

Rare
  • Fainting

  • increased dizziness

  • slow pulse

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Burning, itching, or prickling of the scalp

  • chills

  • goosebumps

  • urinary frequency, retention, or urgency

Less common
  • Anxiety or nervousness

  • confusion

  • dry mouth

  • flushing

  • headache or feeling of pressure in the head

  • skin rash

Rare
  • Backache

  • canker sores

  • dizziness

  • drowsiness

  • dry skin

  • leg cramps

  • pain or sensitivity of the skin to touch

  • stomach problems such as gas, heartburn, or nausea

  • trouble seeing

  • trouble with sleeping

  • weakness

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Orvaten side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Orvaten resources


  • Orvaten Side Effects (in more detail)
  • Orvaten Use in Pregnancy & Breastfeeding
  • Orvaten Drug Interactions
  • Orvaten Support Group
  • 0 Reviews for Orvaten - Add your own review/rating


  • Orvaten MedFacts Consumer Leaflet (Wolters Kluwer)

  • Midodrine Prescribing Information (FDA)

  • midodrine Concise Consumer Information (Cerner Multum)

  • Midodrine Hydrochloride Monograph (AHFS DI)

  • ProAmatine Prescribing Information (FDA)



Compare Orvaten with other medications


  • Dysautonomia
  • Hypotension
  • Postural Orthostatic Tachycardia Syndrome

Sunday, 3 July 2011

Demadex


Generic Name: torsemide (TORE se mide)

Brand Names: Demadex


What is Demadex (torsemide)?

Torsemide is a loop diuretic (water pill) that prevents your body from absorbing too much salt, allowing the salt to instead be passed in your urine.


Torsemide treats fluid retention (edema) in people with congestive heart failure, liver disease, or a kidney disorder such as nephrotic syndrome. This medication is also used to treat high blood pressure (hypertension).


Torsemide may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Demadex (torsemide)?


Do not use this medication if you are allergic to torsemide or if you are unable to urinate

Before using this medication, tell your doctor if you have kidney disease or liver disease, or an allergy to sulfa drugs..


To be sure this medication is not causing harmful effects, your blood will need to be tested on a regular basis. Do not miss any scheduled appointments.


Avoid becoming dehydrated. Follow your doctor's instructions about the type and amount of liquids you should drink while you are taking torsemide.


If you are being treated for high blood pressure, keep using this medication even if you feel fine. High blood pressure often has no symptoms.


What should I discuss with my healthcare provider before taking Demadex (torsemide)?


Do not use this medication if you are allergic to torsemide, or if you are unable to urinate.

If you have any of these other conditions, you may need a dose adjustment or special tests to safely take torsemide:


  • kidney disease;

  • cirrhosis or other liver disease; or


  • an allergy to sulfa drugs.




FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether torsemide passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I take Demadex (torsemide)?


Take this medication exactly as it was prescribed for you. Do not take the medication in larger amounts, or take it for longer than recommended by your doctor. Follow the directions on your prescription label.


Your doctor may occasionally change your dose to make sure you get the best results from this medication.


To be sure this medication is not causing harmful effects, your blood will need to be tested on a regular basis. Do not miss any scheduled appointments.


If you are being treated for high blood pressure, keep using this medication even if you feel fine. High blood pressure often has no symptoms.


Store this medication at room temperature away from heat, light, and moisture. Do not allow the tablets to freeze.

See also: Demadex dosage (in more detail)

What happens if I miss a dose?


Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at the next regularly scheduled time. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include ringing in your ears, loss of appetite, weakness, dizziness, or confusion.


What should I avoid while taking Demadex (torsemide)?


Avoid becoming dehydrated. Follow your doctor's instructions about the type and amount of liquids you should drink while you are taking torsemide.


What are the possible side effects of torsemide


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using torsemide and call your doctor at once if you have a serious side effect such as:

  • dry mouth, thirst, nausea, vomiting;




  • feeling weak, drowsy, restless, or light-headed;




  • fast or uneven heartbeat;




  • muscle pain or weakness;




  • coughing up blood;




  • bloody or black, tarry stools; or




  • hearing loss.



Less serious side effects may include:



  • diarrhea or constipation;




  • headache;




  • dizziness; or




  • decreased sex drive, impotence, or difficulty having an orgasm.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Demadex (torsemide)?


Before taking this medication, tell your doctor if you are using any of the following drugs:



  • lithium (Lithobid, Eskalith);




  • digoxin (Lanoxin);




  • steroids (prednisone and others);




  • ethacrynic acid (Edecrin);




  • cholestyramine (Prevalite, Questran);




  • probenecid (Benemid);




  • amikacin (Amikin), gentamicin (Garamycin), streptomycin, tobramycin (Nebcin, Tobi);




  • salicylates such as aspirin, Disalcid, Doan's Pills, Dolobid, Salflex, Tricosal, and others; or




  • indomethacin (Indocin).



This list is not complete and there may be other drugs that can interact with torsemide. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.



More Demadex resources


  • Demadex Side Effects (in more detail)
  • Demadex Dosage
  • Demadex Use in Pregnancy & Breastfeeding
  • Drug Images
  • Demadex Drug Interactions
  • Demadex Support Group
  • 0 Reviews for Demadex - Add your own review/rating


  • Demadex Prescribing Information (FDA)

  • Demadex MedFacts Consumer Leaflet (Wolters Kluwer)

  • Demadex Monograph (AHFS DI)

  • Demadex Advanced Consumer (Micromedex) - Includes Dosage Information

  • Torsemide Prescribing Information (FDA)

  • Torsemide Professional Patient Advice (Wolters Kluwer)



Compare Demadex with other medications


  • Ascites
  • Edema
  • Heart Failure
  • High Blood Pressure
  • Nonobstructive Oliguria
  • Renal Failure


Where can I get more information?


  • Your pharmacist can provide more information about torsemide.

See also: Demadex side effects (in more detail)


Tuesday, 28 June 2011

Dimetapp DM


Generic Name: brompheniramine/dextromethorphan/phenylpropanolamine (brome fen IR a meen/dex troe meth OR fan/fen ill proe pa NOLE a meen)

Brand Names: Delhistine DM, Dimetapp Cold and Cough Liquigel, Dimetapp DM, DM Cold and Cough, Histinex DM, Iohist DM, Liquihistine DM, Poly DM, Poly Histine DM, Prohistine DM, Trihist DM


What is Dimetapp DM (brompheniramine/dextromethorphan/phenylpropanolamine)?

Brompheniramine is an antihistamine. It blocks the effects of the naturally occurring chemical histamine in your body. Brompheniramine prevents sneezing; itchy, watery eyes and nose; and other symptoms of allergies and hay fever.


Dextromethorphan is a cough suppressant. It suppresses an area in the brain that causes coughing


Phenylpropanolamine is a decongestant. It constricts (shrinks) blood vessels (veins and arteries). This reduces the blood flow, allowing nasal passages to open up.


Brompheniramine/dextromethorphan/phenylpropanolamine is used to treat nasal congestion, sinusitis (inflammation of the sinuses), and coughs associated with allergies, hay fever, and the common cold.


Phenylpropanolamine, an ingredient in this product, has been associated with an increased risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is low, the U.S. Food and Drug Administration (FDA) recommends that consumers not use any products that contain phenylpropanolamine.


Brompheniramine/dextromethorphan/phenylpropanolamine may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about Dimetapp DM (brompheniramine/dextromethorphan/phenylpropanolamine)?


Phenylpropanolamine, an ingredient in this product, has been associated with an increased risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is low, the U.S. Food and Drug Administration (FDA) recommends that consumers not use any products that contain phenylpropanolamine.


Use caution when driving, operating machinery, or performing other hazardous activities. Brompheniramine/dextromethorphan/phenylpropanolamine may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking brompheniramine/dextromethorphan/phenylpropanolamine.

Do not take more of this medication than is recommended. If your symptoms do not improve, or if they worsen, talk to your doctor.


Who should not take Dimetapp DM (brompheniramine/dextromethorphan/phenylpropanolamine)?


Do not take brompheniramine/dextromethorphan/phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Before taking this medication, tell your doctor if you have


  • kidney disease,

  • liver disease,


  • diabetes,




  • glaucoma,




  • any type of heart disease or high blood pressure,




  • thyroid disease,




  • emphysema or chronic bronchitis, or




  • difficulty urinating or have an enlarged prostate.



You may not be able to take brompheniramine/dextromethorphan/phenylpropanolamine, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.


It is not known whether brompheniramine/dextromethorphan/phenylpropanolamine will harm an unborn baby. Do not take this medication without first talking to your doctor if you are pregnant. Brompheniramine/dextromethorphan/phenylpropanolamine passes into breast milk. Do not take this medication without first talking to your doctor if you are breast-feeding a baby. If you are over 65 years of age, you may be more likely to experience side effects from brompheniramine/dextromethorphan/phenylpropanolamine. You may require a lower dose of this medication. Read the package label for directions or consult your doctor or pharmacist before treating a child with this medication. Children are more susceptible than adults to the effects of medicines and may have unusual reactions.

How should I take Dimetapp DM (brompheniramine/dextromethorphan/phenylpropanolamine)?


Take brompheniramine/dextromethorphan/phenylpropanolamine exactly as directed. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.


Take each dose with a full glass of water.

To ensure that you get a correct dose, measure the liquid forms of brompheniramine/dextromethorphan/phenylpropanolamine with a special dose-measuring spoon or cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist where you can get one.


Do not take more of this medication than is recommended. An overdose of this medication can cause serious harm.

Do not take brompheniramine/dextromethorphan/phenylpropanolamine for longer than 7 days in a row. If your symptoms do not improve, if they get worse, or if you have a fever, talk to your doctor.


Store brompheniramine/dextromethorphan/phenylpropanolamine at room temperature away from moisture and heat.

What happens if I miss a dose?


Take the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and take only the next regularly scheduled dose. Do not take a double dose of this medication.


What happens if I overdose?


Seek emergency medical attention.

Symptoms of a brompheniramine/dextromethorphan/phenylpropanolamine overdose include dry mouth, large pupils, flushing, nausea, vomiting, hyperactivity, or hallucinations.


What should I avoid while taking Dimetapp DM (brompheniramine/dextromethorphan/phenylpropanolamine)?


Use caution when driving, operating machinery, or performing other hazardous activities. Brompheniramine/dextromethorphan/phenylpropanolamine may cause dizziness. If you experience dizziness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking brompheniramine/dextromethorphan/phenylpropanolamine.

Brompheniramine/dextromethorphan/phenylpropanolamine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if brompheniramine/dextromethorphan/phenylpropanolamine is taken with any of these medications.


Dimetapp DM (brompheniramine/dextromethorphan/phenylpropanolamine) side effects


Serious side effects are unlikely to occur. Stop taking brompheniramine/dextromethorphan/phenylpropanolamine and seek emergency medical attention if you experience an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives).

Other, less serious side effects may be more likely to occur. Continue to take brompheniramine/dextromethorphan/phenylpropanolamine and talk to your doctor or try another similar medication if you experience



  • dryness of the eyes, nose, and mouth;




  • drowsiness or dizziness;




  • blurred vision;




  • difficulty urinating; or




  • excitation in children.



Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.


What other drugs will affect Dimetapp DM (brompheniramine/dextromethorphan/phenylpropanolamine)?


Do not take brompheniramine/dextromethorphan/phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Do not take other over-the-counter cough, cold, allergy, diet, or sleep aids while taking brompheniramine/dextromethorphan/phenylpropanolamine without first talking to your doctor or pharmacist. Other medications may also contain brompheniramine, dextromethorphan, phenylpropanolamine, or other similar drugs. You may accidentally take too much of these medicines.


Brompheniramine/dextromethorphan/phenylpropanolamine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if brompheniramine/dextromethorphan/phenylpropanolamine is taken with any of these medications.


Drugs other than those listed here may also interact with brompheniramine/dextromethorphan/phenylpropanolamine. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.



More Dimetapp DM resources


  • Dimetapp DM Drug Interactions
  • Dimetapp DM Support Group
  • 0 Reviews for Dimetapp DM - Add your own review/rating


  • Anaplex DMX Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

  • Bromdex D Prescribing Information (FDA)

  • Bromfed DM Elixir MedFacts Consumer Leaflet (Wolters Kluwer)

  • Bromfed DM Prescribing Information (FDA)

  • Myphetane DX Prescribing Information (FDA)

  • Neo DM Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

  • Resperal-DM Drops MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Dimetapp DM with other medications


  • Cold Symptoms


Where can I get more information?


  • Your pharmacist has additional information about brompheniramine/ dextromethorphan/phenylpropanolamine written for health professionals that you may read.

What does my medication look like?


Brompheniramine/dextromethorphan/phenylpropanolamine is available over the counter and with a prescription in many different formulations. Ask your pharmacist any questions you have about this medication, especially if it is new to you.



Saturday, 25 June 2011

Germentin




Germentin may be available in the countries listed below.


Ingredient matches for Germentin



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Germentin in the following countries:


  • Ireland

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Germentin in the following countries:


  • Ireland

International Drug Name Search

Friday, 24 June 2011

Helixate




In the US, Helixate (antihemophilic factor systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Hemophilia A.

US matches:

  • Helixate FS recombinant

  • Helixate FS

Ingredient matches for Helixate



Coagulation Factor VIII , Human (rDNA)

Coagulation Factor VIII , Human (rDNA) Octocog Alfa (a derivative of Coagulation Factor VIII , Human (rDNA)) is reported as an ingredient of Helixate in the following countries:


  • Austria

  • Belgium

  • Canada

  • Denmark

  • Germany

  • Greece

  • Iceland

  • Italy

  • Luxembourg

  • Netherlands

  • Switzerland

  • United States

International Drug Name Search

Thursday, 23 June 2011

Rowapraxin




Rowapraxin may be available in the countries listed below.


Ingredient matches for Rowapraxin



Pipoxolan

Pipoxolan is reported as an ingredient of Rowapraxin in the following countries:


  • Luxembourg

  • Taiwan

Pipoxolan hydrochloride (a derivative of Pipoxolan) is reported as an ingredient of Rowapraxin in the following countries:


  • Oman

International Drug Name Search

Monday, 20 June 2011

Mefenaminsäure Sandoz




Mefenaminsäure Sandoz may be available in the countries listed below.


Ingredient matches for Mefenaminsäure Sandoz



Mefenamic Acid

Mefenamic Acid is reported as an ingredient of Mefenaminsäure Sandoz in the following countries:


  • Switzerland

International Drug Name Search

Monday, 6 June 2011

Valtrex




In the US, Valtrex (valacyclovir systemic) is a member of the drug class purine nucleosides and is used to treat Cold Sores, Cytomegalovirus Infection, Herpes Simplex - Mucocutaneous/Immunocompetent Host, Herpes Simplex - Mucocutaneous/Immunocompromised Host, Herpes Simplex - Suppression, Herpes Zoster and Varicella-Zoster.

US matches:

  • Valtrex

UK matches:

  • Valtrex Tablets 250mg (SPC)

Ingredient matches for Valtrex



Valacyclovir

Valaciclovir is reported as an ingredient of Valtrex in the following countries:


  • Australia

  • Chile

  • Finland

  • Greece

  • Hong Kong

  • Latvia

  • Peru

  • Philippines

  • Poland

  • Slovakia

  • Turkey

  • United Kingdom

Valaciclovir hydrochloride (a derivative of Valaciclovir) is reported as an ingredient of Valtrex in the following countries:


  • Antigua & Barbuda

  • Argentina

  • Aruba

  • Austria

  • Bahamas

  • Bahrain

  • Barbados

  • Bermuda

  • Brazil

  • Canada

  • Cayman Islands

  • Colombia

  • Costa Rica

  • Czech Republic

  • Dominican Republic

  • Ecuador

  • El Salvador

  • Estonia

  • Finland

  • Georgia

  • Germany

  • Grenada

  • Guatemala

  • Guyana

  • Honduras

  • Iceland

  • Indonesia

  • Iran

  • Ireland

  • Israel

  • Jamaica

  • Japan

  • Kuwait

  • Lithuania

  • Malaysia

  • Malta

  • Netherlands Antilles

  • New Zealand

  • Nicaragua

  • Norway

  • Oman

  • Panama

  • Portugal

  • Qatar

  • Romania

  • Russian Federation

  • Saint Lucia

  • Singapore

  • Slovenia

  • Spain

  • Sweden

  • Switzerland

  • Taiwan

  • Thailand

  • Trinidad & Tobago

  • United Arab Emirates

  • United Kingdom

  • United States

  • Venezuela

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 5 June 2011

Lerskin




Lerskin may be available in the countries listed below.


Ingredient matches for Lerskin



Desoximetasone

Desoximetasone is reported as an ingredient of Lerskin in the following countries:


  • Indonesia

International Drug Name Search

Saturday, 28 May 2011

Relefact TRH




Relefact TRH may be available in the countries listed below.


Ingredient matches for Relefact TRH



Protirelin

Protirelin is reported as an ingredient of Relefact TRH in the following countries:


  • Canada

  • Greece

  • Israel

International Drug Name Search

Monday, 23 May 2011

Citalopram Cinfa




Citalopram Cinfa may be available in the countries listed below.


Ingredient matches for Citalopram Cinfa



Citalopram

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Citalopram Cinfa in the following countries:


  • Spain

International Drug Name Search

Saturday, 21 May 2011

Clacina




Clacina may be available in the countries listed below.


Ingredient matches for Clacina



Clarithromycin

Clarithromycin is reported as an ingredient of Clacina in the following countries:


  • Portugal

International Drug Name Search

Permetrina




Permetrina may be available in the countries listed below.


Ingredient matches for Permetrina



Permethrin

Permethrin is reported as an ingredient of Permetrina in the following countries:


  • Latvia

International Drug Name Search

Friday, 20 May 2011

Ofloxat




Ofloxat may be available in the countries listed below.


Ingredient matches for Ofloxat



Ofloxacin

Ofloxacin is reported as an ingredient of Ofloxat in the following countries:


  • Japan

International Drug Name Search

Thursday, 19 May 2011

Pinavérium Merck




Pinavérium Merck may be available in the countries listed below.


Ingredient matches for Pinavérium Merck



Pinaverium Bromide

Pinaverium Bromide is reported as an ingredient of Pinavérium Merck in the following countries:


  • France

International Drug Name Search

Saturday, 14 May 2011

Baxmune




Baxmune may be available in the countries listed below.


Ingredient matches for Baxmune



Mycophenolic Acid

Mycophenolic Acid mofetil (a derivative of Mycophenolic Acid) is reported as an ingredient of Baxmune in the following countries:


  • India

International Drug Name Search

Otomide




Otomide may be available in the countries listed below.


Ingredient matches for Otomide



Hexamidine

Hexamidine diisetionate (a derivative of Hexamidine) is reported as an ingredient of Otomide in the following countries:


  • France

Lidocaine

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Otomide in the following countries:


  • France

International Drug Name Search

Tuesday, 10 May 2011

Sulfato de Atropina Larjan




Sulfato de Atropina Larjan may be available in the countries listed below.


Ingredient matches for Sulfato de Atropina Larjan



Atropine

Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Sulfato de Atropina Larjan in the following countries:


  • Argentina

International Drug Name Search

Tuesday, 3 May 2011

Elmonase




Elmonase may be available in the countries listed below.


Ingredient matches for Elmonase



Elastase

Elastase is reported as an ingredient of Elmonase in the following countries:


  • Japan

International Drug Name Search

Monday, 2 May 2011

Ribavirin Solution


Pronunciation: RYE-ba-VIR-in
Generic Name: Ribavirin
Brand Name: Rebetol

Ribavirin Solution may cause serious birth defects and/or fetal death when used during pregnancy. It should not be used by women who are pregnant or by men whose female partners are pregnant. Women of childbearing potential who either take Ribavirin Solution or are sexual partners of men who take Ribavirin Solution must:


  • have a negative pregnancy test immediately before therapy with Ribavirin Solution is started.

  • avoid becoming pregnant during therapy with Ribavirin Solution or within the first 6 months after Ribavirin Solution is stopped.

At least 2 reliable forms of effective birth control must be used during treatment with Ribavirin Solution and for 6 months after treatment with Ribavirin Solution is stopped.


Use of Ribavirin Solution alone is not effective for treating chronic hepatitis C infection. Ribavirin Solution must be used with another medicine (interferon) in order to treat hepatitis C infection.


Ribavirin Solution may cause serious blood problems (hemolytic anemia), which can cause serious and sometimes fatal heart attacks in patients who have heart disease. Do not take Ribavirin Solution if you have a history of serious or uncontrolled heart problems.





Ribavirin Solution is used for:

Treating chronic hepatitis C infection in certain patients when used in combination with interferon. It may also be used for other conditions as determined by your doctor.


Ribavirin Solution is an antiviral medicine. Exactly how it works to treat hepatitis C is not known.


Do NOT use Ribavirin Solution if:


  • you are allergic to any ingredient in Ribavirin Solution or have had a severe allergic reaction (eg, red, swollen, blistered, or peeling skin) to ribavirin or any other ingredient in Ribavirin Solution

  • you are pregnant or planning to become pregnant while you take Ribavirin Solution or within 6 months after you stop taking it

  • you are a man with a female sexual partner who is pregnant or planning to become pregnant while you take Ribavirin Solution or within 6 months after you stop taking it

  • you have certain blood disorders (eg, hemolytic anemia, sickle cell anemia, thalassemia major), a history of serious or uncontrolled heart problems, severe kidney problems, or inflammation of the pancreas (acute pancreatitis)

  • you have autoimmune hepatitis (liver problems caused by your own body instead of a virus)

  • you are taking didanosine

Contact your doctor or health care provider right away if any of these apply to you.



Before using Ribavirin Solution:


Some medical conditions may interact with Ribavirin Solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you have a female sexual partner who is of childbearing age

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of cancer, heart problems or a heart attack, high blood pressure, kidney problems, diabetes, pancreas problems, lung or breathing problems, sarcoidosis, blood problems (eg, anemia, spherocytosis), stomach or bowel bleeding, thyroid problems, HIV infection or other immune system problems, or eye or vision problems

  • if you have liver problems other than hepatitis C infection (eg, hepatitis B infection), cirrhosis of the liver, or decreased liver function

  • if you have a history of mood or mental disorders (eg, depression), thoughts of suicide, or suicidal behavior

  • if you have used interferon before to treat hepatitis C and it did not work

  • if you had an organ transplant

  • if you have a history of drug or alcohol abuse

Some MEDICINES MAY INTERACT with Ribavirin Solution. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Didanosine or other nucleoside reverse transcriptase inhibitors (NRTIs) (eg, lamivudine), other antiretroviral medicines for HIV infection, or thiopurines (eg, azathioprine) because serious side effects, including risk of infection, nerve problems (peripheral neuropathy), pancreas problems, bone marrow suppression, lactic acidosis, and severe or fatal liver failure, may be increased by Ribavirin Solution

  • Anticoagulants (eg, warfarin) or certain NRTIs (eg, lamivudine, stavudine, zidovudine) because their effectiveness may be decreased by Ribavirin Solution

This may not be a complete list of all interactions that may occur. Ask your health care provider if Ribavirin Solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Ribavirin Solution:


Use Ribavirin Solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Ribavirin Solution comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Ribavirin Solution refilled.

  • Take Ribavirin Solution by mouth with food.

  • Drinking extra fluids while you are taking Ribavirin Solution is recommended. Check with your doctor for instructions.

  • Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.

  • Take Ribavirin Solution on a regular schedule to get the most benefit from it. Taking Ribavirin Solution at the same times each day will help you remember to take it.

  • Continue to take Ribavirin Solution even if you feel well. Do not miss any doses.

  • If you miss a dose of Ribavirin Solution, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Ribavirin Solution.



Important safety information:


  • Ribavirin Solution may cause dizziness or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Ribavirin Solution with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Avoid drinking alcohol, including beer, wine, and liquor, because it could worsen liver disease.

  • At least 2 reliable forms of effective birth control must be used during treatment by men and women who take Ribavirin Solution and for 6 months after Ribavirin Solution is stopped. Men who take Ribavirin Solution should use a condom with spermicide as 1 of the 2 forms of birth control.

  • Women of childbearing potential who either take Ribavirin Solution or are sexual partners of men who take Ribavirin Solution must have a pregnancy test before therapy with Ribavirin Solution is started, monthly during therapy, and monthly for 6 months after Ribavirin Solution is stopped.

  • Patients who take Ribavirin Solution may be at increased risk of suicidal thoughts or actions. The risk may be greater in patients who have had suicidal thoughts or actions in the past. The risk may also be greater in patients who have had bipolar (manic-depressive) illness, or if their family members have had it. Watch patients who take Ribavirin Solution closely. Contact the doctor at once if new, worsened, or sudden symptoms such as depressed mood; anxious, restless, or irritable behavior; panic attacks; or any unusual change in mood or behavior occur. Contact the doctor right away if any signs of suicidal thoughts or actions occur.

  • Ribavirin Solution may lower the ability of your body to fight infection. Avoid contact with people who have colds or infections. Tell your doctor if you notice signs of infection like fever, sore throat, rash, or chills.

  • Ribavirin Solution may cause dry mouth and increase the risk of teeth and gum problems. Proper dental care is important while you are taking Ribavirin Solution. Brush and floss your teeth carefully at least twice a day and visit the dentist regularly.

  • If vomiting occurs while you are taking Ribavirin Solution, be sure to rinse your mouth and clean your teeth afterwards.

  • Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.

  • Lab tests, including pregnancy; complete blood cell counts; hemoglobin or hematocrit levels; heart, liver, kidney, thyroid, and lung function; and eye exams, may be performed while you use Ribavirin Solution. These tests may be used to monitor your progress or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Ribavirin Solution with caution in the ELDERLY; they may be more sensitive to its effects, especially anemia.

  • Ribavirin Solution may affect growth rate in CHILDREN and teenagers in some cases. They may need regular growth checks while they take Ribavirin Solution.

  • Use Ribavirin Solution with extreme caution in CHILDREN younger than 3 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: Do not use Ribavirin Solution if you are pregnant. Avoid becoming pregnant while you are taking it. If you think you may be pregnant, contact your doctor right away. It is not known if Ribavirin Solution is found in breast milk. Do not breast-feed while taking Ribavirin Solution.


Possible side effects of Ribavirin Solution:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; cough; diarrhea; dizziness; dry mouth; dry skin; loss of appetite; mild headache, nausea, or vomiting; sinus problems; tiredness; upset stomach; weakness or fatigue.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); changes in hearing, taste, or vision; chest pain; dark, tarry, or bloody stools; dark urine; decrease in the amount of urine; fainting; fever, chills, or sore throat; hair loss; joint pain; mood or mental problems (eg, agitation, aggression, anger, anxiety, decreased concentration, depression, irritability, nervousness); menstrual problems; muscle pain or weakness; numbness of an arm or leg; pale stools; prolonged nausea and vomiting; rapid breathing; red, swollen, blistered, or peeling skin; severe headache; severe or persistent diarrhea; severe stomach or back pain; shortness of breath; suicidal thoughts or actions; trouble sleeping; unusual bruising or bleeding; unusual or severe tiredness, weakness, or fatigue; weight loss; yellowing of the eyes or skin.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Ribavirin side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Ribavirin Solution:

Store Ribavirin Solution at 77 degrees F (25 degrees C), Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C), or in the refrigerator, between 36 and 46 degrees F (2 and 8 degrees C) is permitted. Do not freeze. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Ribavirin Solution out of the reach of children and away from pets.


General information:


  • If you have any questions about Ribavirin Solution, please talk with your doctor, pharmacist, or other health care provider.

  • Ribavirin Solution is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Ribavirin Solution. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Ribavirin resources


  • Ribavirin Side Effects (in more detail)
  • Ribavirin Use in Pregnancy & Breastfeeding
  • Drug Images
  • Ribavirin Drug Interactions
  • Ribavirin Support Group
  • 1 Review for Ribavirin - Add your own review/rating


Compare Ribavirin with other medications


  • Hepatitis C
  • Respiratory Syncytial Virus